Atlas Trials

An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate

Clinical trial NCT01844869 · COMPLETED

Trial details

NCT number
NCT01844869
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hematologic MalignanciesSolid Tumors
Start date
2013-07-01
Primary completion
2014-12-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.